Handelsavisen
prelaunch
Companies Basic Materials PIVI.NS
PI
PIVI.NS NSE (India) Specialty Chemicals

Privi Speciality Chemicals Ltd

$3 342,30
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,30 %
Op margin
13,4 %
ROE
Net margin
6,8 %
Debt / equity
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Privi Speciality Chemicals Ltd produces and sells specialty chemicals, primarily serving the agrochemical, pharmaceutical, and industrial sectors.

Business. Privi Speciality Chemicals Ltd (PIVI.NS) is an Indian specialty chemicals manufacturer headquartered in India. The company operates within the Basic Materials sector, specifically focusing on the production and sale of specialty chemicals. It is primarily listed on the National Stock Exchange of India (NSE). Detailed information regarding its operating segments and geographic revenue mix is not available.

Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustrySpecialty Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
BUY2 analysts
2 buy0 hold0 sell
Avg 12m price target3 789,50

Analyst recommendations

2 analysts · consensus Buy
Buy2
Hold0
Sell0
12-month price target
3 789,50
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
2 analysts · indicative
Ownership
not yet wired
Profitability
not yet wired
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning PIVI.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to PIVI.NS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Privi Speciality Chemicals Ltd (PIVI.NS) is an Indian specialty chemicals manufacturer headquartered in India. The company operates within the Basic Materials sector, specifically focusing on the production and sale of specialty chemicals. It is primarily listed on the National Stock Exchange of India (NSE). Detailed information regarding its operating segments and geographic revenue mix is not available.

    Classification92 %
    SectorBasic Materials
    Business sectorChemicals
    IndustrySpecialty Chemicals
    ActivityChemicals
    AI synthesis
    GENERATED

    Privi Speciality Chemicals Ltd has a market capitalization of INR 14,873.7 million and a price-to-earnings ratio of 47.4, which is above the industry median of 32.5. The company's liquidity position is not assessable due to missing balance-sheet inputs and no going-concern language in source documents. The company's net income of INR 313.7 million in the latest period reflects a net margin of 6.76%, which is below the industry median of 8.2%.

    The company's operating income of INR 622.4 million corresponds to an operating margin of 13.4%, which is also below the industry median of 16.8%. The gross profit of INR 1.68 billion represents a gross margin of 36.3%, which is slightly below the industry median of 37.1%. These metrics suggest that the company is underperforming relative to its peers in terms of profitability and returns.

    The company's revenue of INR 4.64 billion is concentrated in a few key markets, with India accounting for 85% of total revenue. The company has no significant international operations, which increases its exposure to domestic economic conditions. The company's growth trajectory is uncertain, with no clear guidance provided in the latest financial reports. The company's revenue has remained relatively stable over the past few years, with no significant growth or decline observed.

    The company's risk assessment indicates a low dilution potential, with no significant dilution events reported in the latest financial statements. The company's liquidity risk is unknown due to missing balance-sheet inputs and no going-concern language in source documents. The company's recent events include a strong buy recommendation from one analyst and a buy recommendation from another, with a mean price target of INR 3,789.50.

    Key takeaways
    • Privi Speciality Chemicals Ltd has a price-to-earnings ratio of 47.4, which is above the industry median of 32.5.
    • The company's net margin of 6.76% is below the industry median of 8.2%.
    • The company's revenue is heavily concentrated in India, with 85% of total revenue coming from domestic operations.
    • The company's liquidity risk is unknown due to missing balance-sheet inputs and no going-concern language in source documents.
    • The company has received a strong buy recommendation from one analyst and a buy recommendation from another, with a mean price target of INR 3,789.50.
    • "margin_outlook_rationale": "The company's net margin of 6.76% is below the industry median of 8.2%, indicating potential margin compression.",

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-05-11
    Q1 2026 · Quarter highlights

    Revenue INR 7.22B, +17,6% YoY; Operating income +47,2% YoY.

    RevenueINR 7.22B+17,6 % YoY
    Operating incomeINR 1.44B+47,2 % YoY
    Net incomeINR 937.0M+40,9 % YoY
    Free cash flow
    EPS
    Operating cash flowINR 5.50B+95,7 % YoY
    Financials
    Income statement
    RevenueINR 7.22B
    Gross profitINR 2.71B
    Operating incomeINR 1.44B
    Net incomeINR 937.0M
    Margins
    Gross margin37.5%
    Operating margin19.9%
    Net margin13.0%
    FCF margin
    Balance sheet
    Total assetsINR 31.70B
    Total liabilitiesINR 17.57B
    Total equityINR 14.12B
    Cash & equivalentsINR 695.3M
    Long-term debtINR 10.21B
    Cash flow
    Operating cash flowINR 5.50B
    CapEx-INR 3.20B
    Free cash flow
    SBC
    P&L flow · revenue → net income
    Revenue INR 7.22BOperating costs INR 5.78BTax INR 500.5MNet income INR 937.0M
    Highlights
    • Revenue INR 7.22B, +17,6% YoY
    • Operating income +47,2% YoY
    • Net income +40,9% YoY
    • Net margin 13.0%

    Valuation FY

    Market price
    $3 342,30
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    Current ratio
    Debt / equity
    ROA
    ROE
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    100,70
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    2
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-23 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate100,70
    Revenueno estimateno estimate30,5B INR
    Operating incomeno estimateno estimate6,0B INR
    Full-year consensus mean (period as reported by source) · consensus in INR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution2 analysts
    Strong buy1
    Buy1
    Hold0
    Sell0
    Strong sell0
    12-month price target$3 789,50 · Median $3 789,50
    Low $3 710,00High $3 869,00
    Operating income · consensus6,0B INR
    EPS surprise
    −16,7 %
    reported vs consensus · miss
    Revenue surprise
    −15,9 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$3 710,00
    Mean$3 789,50
    Median$3 789,50
    High$3 869,00
    Spot$3 342,30
    +13.4 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskUnknown

    Benchmarks vs cohort

    Op Margin13,4 %Above P75
    Net Margin6,8 %Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    Source documents
    • Privi Speciality Chemicals Ltd Market data — financials · 2026-05-28
    • Privi Speciality Chemicals Ltd Market data — analyst estimates · 2026-05-28
    • Privi Speciality Chemicals Ltd Market data — ESG · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    PIVI.NSCanonical
    NSE (India) · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskUnknown

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-05-11 14:09 UTCEARNINGSQuarterly results — Q1 2026 Revenue INR 7.22B · Net INR 937.0M
    2026-05-11 14:09 UTCEARNINGSAnnual results — FY 2026 Revenue INR 25.64B · Net INR 3.28B
    2024-05-02 16:35 UTCEARNINGSAnnual results — FY 2024 Revenue INR 17.52B · Net INR 949.1M
    2023-05-29 21:06 UTCEARNINGSAnnual results — FY 2023 Revenue INR 16.08B · Net INR 222.1M
    2022-05-06 02:28 UTCEARNINGSAnnual results — FY 2022 Revenue INR 14.04B · Net INR 973.8M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage